BIOMAT Database Logo BIOMAT Database Logo

[Immunoreactive insulin and C-peptide in glucose tolerance disturbances in the relatives of diabetes mellitus patients]. 1980

A G Mazovetskiĭ, and P S Zavadskiĭ, and B Tursunov, and V P Masenko

The content of immunoreactive insulin (IRI) and of immunoreactive C-peptide (IRCP) was determined in the relatives of patients with juvenile diabetes mellitus and in healthy persons during the oral glucose tolerance test (GTT). The IRCP content was higher than the IRI content. The IRI and IRCP curves were identical in persons with normal and doubtful GTT results; these curves differed from those in patients with latent and manifest diabetes which were torpid in character. The coefficient of molar IRCP/IRI proportion differed in persons with pathological GTT results as compared with the normal.

UI MeSH Term Description Entries
D007330 Insulin Antibodies Antibodies specific to INSULIN. Antibodies, Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011236 Prediabetic State The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2). Prediabetes,Prediabetic States,State, Prediabetic,States, Prediabetic
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A G Mazovetskiĭ, and P S Zavadskiĭ, and B Tursunov, and V P Masenko
[Relationship between the results of glucose tolerance test and plasma content of immunoreactive insulin in the relatives of patients with juvenile form of diabetes mellitus].
January 1979, Problemy endokrinologii,
A G Mazovetskiĭ, and P S Zavadskiĭ, and B Tursunov, and V P Masenko
[Glucose tolerance test and immunoreactive insulin level in the blood of the relatives of patients with coronary arteriosclerosis].
January 1984, Terapevticheskii arkhiv,
A G Mazovetskiĭ, and P S Zavadskiĭ, and B Tursunov, and V P Masenko
[Clinical role of the determination of immunoreactive insulin and C-peptide in children with diabetes mellitus].
March 1983, Pediatriia,
A G Mazovetskiĭ, and P S Zavadskiĭ, and B Tursunov, and V P Masenko
[The appearance of the C-peptide and immunoreactive insulin concentration curve in various phases of diabetes mellitus].
January 1987, Vojnosanitetski pregled,
A G Mazovetskiĭ, and P S Zavadskiĭ, and B Tursunov, and V P Masenko
Glucose, immunoreactive insulin and C-peptide immunoreactivity in patients with acute viral hepatitis.
July 1983, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
A G Mazovetskiĭ, and P S Zavadskiĭ, and B Tursunov, and V P Masenko
Serum insulin & C-peptide responses in individuals with impaired glucose tolerance & diabetes.
March 1984, The Indian journal of medical research,
A G Mazovetskiĭ, and P S Zavadskiĭ, and B Tursunov, and V P Masenko
Glucose and insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin-dependent diabetes mellitus.
June 1993, Diabetes research and clinical practice,
A G Mazovetskiĭ, and P S Zavadskiĭ, and B Tursunov, and V P Masenko
Glucose tolerance and insulin response in diabetes mellitus of dogs.
February 1978, The Journal of small animal practice,
A G Mazovetskiĭ, and P S Zavadskiĭ, and B Tursunov, and V P Masenko
Letter: Glucose-tolerance tests in HL-A-typed relatives of patients with juvenile onset diabetes mellitus.
December 1975, Lancet (London, England),
A G Mazovetskiĭ, and P S Zavadskiĭ, and B Tursunov, and V P Masenko
Renal handling of insulin and C-peptide in patients with non-insulin-dependent diabetes mellitus.
January 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Copied contents to your clipboard!